Is there any advantage to combined trastuzumab and chemotherapy in perioperative setting her 2neu positive localized gastric adenocarcinoma?
We report here a 44-year-old Moroccan man with resectable gastric adenocarcinoma with overexpression of human epidermal growth factor receptor 2 (HER2) by immunohistochemistry who was treated with trastuzumab in combination with chemotherapy in perioperative setting. He received 3 cycles of neoadjuv...
Main Authors: | Sbitti, Yassir, Essaidi l, Ismail, Debbagh, Adil, Kadiri, Habiba, Oukabli, Mohamed, Moussaid, Yassine, Slimani, Khaoula, Fetohi, Mohamed, Elkaoui, Hakim, Albouzidi, Abderrahmane, Mahi, Mohamed, Ali, Abdelmounaim Ait, Ichou, Mohamed, Errihani, Hassan |
---|---|
Format: | Online |
Language: | English |
Published: |
BioMed Central
2011
|
Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3204255/ |
Similar Items
-
Metachronous pancreatic metastases from renal cell carcinoma: is there a place of Active-Surveillance before deferred deliberately Molecular Target Agent?
by: Sbitti, Yassir, et al.
Published: (2016) -
Renal damage induced by pemetrexed causing drug discontinuation: a case report and review of the literature
by: Yassir Sbitti, et al.
Published: (2017-07-01) -
Diagnostic challenge for ovarian malignant melanoma in premenopausal women: Primary or metastatic?
by: Sbitti, Yassir, et al.
Published: (2011) -
Breast cancer treatment and sexual dysfunction: Moroccan women's perception
by: Sbitti, Yassir, et al.
Published: (2011) -
Treatment of Liver Metastases From Colorectal Cancer: Medico-Surgical Strategies
by: Essadi, Ismail, et al.
Published: (2011)